VANGUARD GROUP INC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$35,944,839
-23.0%
1,406,843
-13.6%
0.00%0.0%
Q2 2023$46,702,971
+33.0%
1,628,416
+11.1%
0.00%0.0%
Q1 2023$35,124,343
+42.8%
1,465,346
+1.0%
0.00%0.0%
Q4 2022$24,599,207
+24.2%
1,450,425
+8.5%
0.00%0.0%
Q3 2022$19,812,000
+5.5%
1,336,818
+12.0%
0.00%0.0%
Q2 2022$18,787,000
-39.6%
1,193,656
+3.5%
0.00%0.0%
Q1 2022$31,099,000
-26.8%
1,153,513
+0.5%
0.00%0.0%
Q4 2021$42,458,000
-20.2%
1,147,222
+3.0%
0.00%0.0%
Q3 2021$53,225,000
+33.3%
1,113,951
-5.6%
0.00%0.0%
Q2 2021$39,926,000
-19.3%
1,179,841
-1.5%
0.00%0.0%
Q1 2021$49,452,000
-3.6%
1,197,380
+1.3%
0.00%0.0%
Q4 2020$51,292,000
+15.3%
1,182,382
+14.0%
0.00%0.0%
Q3 2020$44,495,000
+9.3%
1,037,177
+19.1%
0.00%0.0%
Q2 2020$40,708,000
+1986.5%
870,935
+506.6%
0.00%
Q1 2020$1,951,000
+44.8%
143,581
+15.9%
0.00%
Q4 2019$1,347,000
+5.9%
123,8810.0%0.00%
Q3 2019$1,272,000123,8810.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders